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study question:What is the impact of fetoscopic surgery for isolated Congenital Diaphragmatic Hernia (CDH) on future reproductive
and gynecological outcomes?
summary answer: We did not observe an increase of obstetric or gynecological problems after fetoscopic surgery nor was there an
increased risk for subsequent infertility.
what is known already: The reproductive and gynecological outcomes of patients undergoing open maternal-fetal surgery are
known. The most relevant counseling items are the elevated risk for uterine dehiscence and rupture (up to 14%).
study design, size, duration: Bi-centric studyover a 10-year period including 371women carrying a fetuswith isolatedCDHeither
managed expectantly (n ¼ 167) or operated in utero (n ¼ 204).
participants/materials, setting, methods: Consenting patients ﬁlled out a survey with 23 questions (2 open and 21 mul-
tiple choice). Questionnaires were custom designed to obtain information on subsequent reproductive or gynecological problems as well as psy-
chological impact.
main results and the role of chance: The response rate was 40% (147/371). More women in the FETO group attempted a
subsequent pregnancy: 70% (62/89) when compared with 47% (27/58) in controls (P ¼ 0.009). This coincided with a longer follow-up in the
FETO group (76 versus 59 months; P, 0.001) and a lower survival rate in the index pregnancy (53 versus 72%; P ¼ 0.028). There was no dif-
ference in the number of nulliparous or parous women, neither in the conception rate. In total, therewere 129 subsequent pregnancies. Nobody
reported secondary fertility problems. Four women in the FETO group and one in the control reported a congenital anomaly in a subsequent
pregnancy. Twenty-one pregnancies were reported with at least one complication (FETO: 23% (14/60), controls 27% (7/26)). During delivery
or in the post-partum period 11 patients reported at least 1 complication (FETO 17% (10/59), controls 4% (1/24)). New onset gynecological
problems occurred in 14 participants (10%). None of these events were more likely in one or the other group. Psychological and emotional
impacts were frequent in both the FETO (41%) and the control groups (46%) (P ¼ 0.691).
limitations, reasons for caution: The response rate was 40% (147/371), less than desired. The use of unvalidated self-
reported outcomes may skew exact determination of the nature and severity of medical complications. The number of observations for uncom-
mon events was low. The mean follow-up period to detect gynecological complications may be too short.
wider implications of the findings: This is the ﬁrst evidence that fetoscopic surgery for CDH does not compromise future
reproductive potential or obstetrical outcome when compared with expectant management. A pregnancy complicated by a serious congenital
birth defect, such as CDH, frequently has a measurable psychological impact.
study funding/competing interest: Theauthors haveno conﬂicts todeclare. J.D. receives a fundamental clinical researchgrant
of the Fonds Wetenschappelijk Onderzoek - Vlaanderen (FWO; 18.01207). A.C.E. is supported by the Erasmus+Program of the European
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Introduction
Congenital diaphragmatic hernia (CDH) is a rare condition with a preva-
lence of approximately 1/2500–1/5000 births (Colvin et al., 2005). In
the majority of cases, the defect is located on the left (84%), 13% are
right sided and 2% are bilateral (Torfs et al., 1992). In 40%, the defect
is associated with other congenital malformations with poor prognosis
in those cases (Skari et al., 2000). Current survival rates in population-
based studies vary between 55 and 70% (Jani et al., 2005). Survivors
may have serious morbidity, mostly respiratory in nature as well as
feeding problems and reﬂux, growth and orthopedic problems. The
leading causes of death remain pulmonary hypoplasia and pulmonary
hypertension (Laberge and Flageole, 2007). In utero transfer to specia-
lized, high-volume centers has a signiﬁcant impact on survival (Gallot
et al., 2007; Deprest et al., 2011). In isolated CDH, the outcome corre-
lates with the degree of pulmonary hypoplasia and the position of the
liver. Whether these are independent predictors remain controversial.
Both can be measured by noninvasive imaging methods, such as ultra-
sound and fetal magnetic resonance (Metkus et al., 1996; Claus et al.,
2011).
Based on a severity assessment, fetal therapy can be offered to sub-
groups that have a poor predicted outcome. Currently, this is by feto-
scopic endoluminal tracheal occlusion (FETO), which involves the
percutaneous insertion of a balloon into the trachea. It prevents egress
of lung ﬂuid, inducing growth of the lung by tissue stretch (Deprest
et al., 1998; Khan et al., 2007). FETO apparently increases survival in
fetuses with CDH and severe pulmonary hypoplasia (Jani et al., 2009)
and also improves early neonatal morbidity (Done et al., 2013, 2015).
At thismoment, the efﬁcacy of prenatal intervention is being investigated
in the so-called TOTAL randomized clinical trial (www.totaltrial.eu) that
compares neonatal outcomes after FETO or expectant management
(Jani et al., 2005; Dekoninck et al., 2011).
Fetal surgery forother conditions is also possible throughopen access,
involving general anesthesia, laparotomyandhysterotomy(referred toas
‘open’ maternal-fetal surgery (OMFS)). Maternal risks include surgical
bleeding, pulmonary edema, infection, preterm rupture of membranes,
preterm labor and delivery and, when applicable side effects of medical
therapies, e.g. aggressive tocolysis. Either access method (percutaneous
or open) for fetal surgery, may have long-term risks for the mother. The
reproductive and gynecological outcomes of patients undergoing OMFS
have been reported by Wilson et al. (2004, 2010).
They included all their patients undergoing OMFS presenting with
CDH,myelomeningocele, lethal lung malformations and sacrococcygeal
teratoma.Theydid not observe an increase in the prevalence of congeni-
tal anomalies or fertility problems. However, they did observe a signiﬁ-
cance incidence of uterine dehiscence (14%) and rupture (14%)
(Wilson et al., 2004, 2010).
Such outcome data on endoscopic fetal surgery as far as we are
aware have not been reported. In this study, we aimed to document
reproductive, obstetrical and gynecological outcomes and psychological
impact in women who underwent fetoscopic surgery for CDH at two
institutions. This knowledge is valuable in the counseling of future families
when faced with a severe fetal anomaly such as CDH, who would con-
sider fetal surgery or participation to the TOTAL trail (Dekoninck
et al., 2011).
Materials andMethods
Thiswas a bi-centric cohort study conducted at the fetalmedicine units of the
UniversityHospitals LeuvenandHospitalClı´nic Barcelona spanning a10-year
period from2002onwards. The studywas approvedby the local EthicsCom-
mittees on clinical studies. We searched our database for all women who
were prenatally diagnosed with CDH without associated structural or
genetic anomalies. Women who requested termination of pregnancy or in
whom the diagnosis of nonisolated CDH was made in the post-natal
period were excluded. The minimum follow-up period following birth in
the index pregnancy was 1 year at the start of the study. Our search resulted
in 371 eligible patients. These were categorized as either expectantly
managed during pregnancy (controls) or as having undergone fetal surgery
(FETO group). The latter patients by deﬁnition had a fetus with severe lung
hypoplasia. The controls overall had milder hypoplasia, or, in case of
severe hypoplasia, declined fetal surgery. Therefore, severity of hypoplasia,
hence expected pregnancy outcome, should be worse in the FETO group.
First, allwoman receivedwritten information concerning thepurposeandde-
scription of the study and an informed consent form. Of those patients with
whom we had email contact, this was done via email; the other patients
received the same information by standard mail.
Once consenting, participants were offered two options to ﬁll out the
questionnaire, either via Limesurvey (v. 2.00+, The LimeSurvey Project
Team, GPL); or, alternatively, via a printed questionnaire to be returned in
a prepaid envelope. The questionnaire we used was based on the one
designed byWilson et al. (2004, 2010) and previously used in patients under-
goingOMFS (Supplementary data). Though that questionnaire is not formally
validated their work is considered unique and represents a landmark study.
We supplemented it with an additional ﬁve questions assessing gynecological
problems. Brieﬂy, participants were asked to self-report the occurrence of
reproductive, obstetric, gynecological, psychological and/or emotional pro-
blems since their index pregnancy. In total, the questionnaire covered 23
items, i.e. 21 multiple choice and 2 open questions (Supplementary data).
Questions 1–4 documented the interval between index and further preg-
nancy attempts; in the case of no further attempts, the patient was asked
in an open question if there was any relationship of that decision to her pre-
vious complicated pregnancy or with the disease process in the index child.
For those who attempted further conception, Question 5–15 were con-
cerned with fertility issues, and when pregnant, for miscarriage, pregnancy
complications, preterm labor, preterm rupture of the membranes, uterine
rupture, placentation problems or post-partum hemorrhage. Question 16
asked participants for any potential emotional and psychological problems,
leaving the participants to describe their nature in open Question 17.
Questions 18–23 asked for the occurrence of new gynecological problems
or abdominal pain. The questionnaire was available in Dutch, French,
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English, Spanish and Italian, languages spoken or understood by the patients
managed.
Themedical records of all invited patientswere searched formaternal age,
parity prior to the index pregnancy, as well as its further management and
outcome, including whether they had fetal surgery.
Statistical analyses
Theanswers fromparticipantswere linked to thedataof themedical records,
pooled in aMicrosoft Excel database (Microsoft Corp, Redmond,WA,USA)
and analyzedwith SPSS (Vs. 20; IBMSoftware, Inc., Armonk,NY,USA).Nor-
mality tests were used to determine distribution. Demographic data are dis-
played by using descriptive statistics such as number, percentage, mean,
standard deviation (SD), median, interquartile range (IQR) and range as ap-
propriate. Categorical variables were analyzed by the Pearson x2 test. The
numerical variables were analyzed with a two-sided t-test. A P-value of
,0.05 was considered signiﬁcant for each analysis.
Results
Of the 371 patients contacted, 204 patients had fetal surgery (FETO
group). There were 167 women who were expectantly managed
during pregnancy (controls), either because severity of lung hypoplasia
was moderate or mild, or, in case of severe hypoplasia, they did not
opt for FETO. The age of invited patients at baseline in Leuven was
2 years less than in Barcelona. The interval between the index pregnancy
and the surveywas 17months longer in Leuven,which coincideswith the
later adoption of FETO in Barcelona. Therewere no differences in parity
or survival rate in the index pregnancy.
Theoverall response ratewas 40%.The only statistically signiﬁcant dif-
ference between participants and nonparticipants was the interval
between the index pregnancy and survey, which was 7 months shorter
in nonparticipants (Table I). The response rate was comparable among
FETO patients (44%, 89/204) and controls (35%; 58/167, P ¼ 0.102).
Table II displays data from the147 consenting participants ofwhom89
underwent fetal surgery (cases) and 58 were controls. More women in
the FETO group attempted a subsequent pregnancy (70% (62/89)
versus 47% (27/58) in controls; P ¼ 0.009). This coincided with a
longer duration of follow-up in the FETO group (76 versus 59 months;
P, 0.001). Also the survival rate in the index pregnancy was lower in
the FETO group (53 versus 72%; P ¼ 0.028). We did not observe a dif-
ference in number of nulliparous or parous women.
In total, therewere129 subsequentpregnancies in 82women (Table II
and Fig. 1). Three participants became pregnant by Assisted Reproduct-
ive Technology (ART); however, we noted they requiredART previously.
Therefore, nonewonset fertility problemswere identiﬁed inour respond-
ing cohort. The chance of conception did not differ between both groups
(FETO 94%, 58/62 and controls 89%, 24/27, P ¼ 0.43). There were no
differences in ﬁrst trimester pregnancy losses. There were no early mid-
trimester losses, and the number of preterm deliveries was not different.
There were few medical problems in gestation. One hundred and ﬁve
women delivered at a viable gestational age. In 21 of these pregnancies
the patient reported 1 or more complications, yet this was not more
likely in FETO than control patients (P ¼ 0.934). Pregnancy outcomes
are further detailed in Table II. Therewere 11 post-partumcomplications.
No participants from the FETO group reported any uterine scar-related
complications like dehiscence or rupture. Five babies had congenital
anomalies.
Overall, 82%ofpatientsofwhomthebabydiedattempted to conceive
again versus 48% in mothers who had a surviving baby in the index
pregnancy. Fifty-eight women did not wish to conceive again (FETO
30%, 27/89; controls 53%, 31/58; P¼ 0.009). Of those, 19 (33%, 19/54)
mentioned that this decision was related to the congenital anomaly in
the index pregnancy. For those 19 women, there was no difference in
management of the index pregnancy (FETO 22%, 6/21, controls 42%,
13/18; P ¼ 0.189). They reported as reasons fear for recurrence
(10/19 patients), psychological distress persisting since the CDH-
pregnancy (6/19) or current and past health problems in the baby
with CDH (5/19). The neonatal death rate in the index pregnancy of
these 19 patients was 11%, whereas it was 21% in the 39 patients who
did not wish to conceive, yet did not mention the index problem as
the reason for that (P ¼ 0.474).
Table III summarizes the psychological problems following the index
pregnancy, as quoted by respondents, irrespective of the further wish
for conception. Reports of psychological and emotional impactwere fre-
quent (43%, 61/141), yet equal in both groups. The most frequent psy-
chological problems were anxiety (n ¼ 19) and depressed mood (n ¼
12). Fourteen women (10%, 14/141) reported new gynecological pro-
blems,mostly abnormal uterine bleeding (n ¼ 7), and chronic abdominal
pain (n ¼ 8) (Table III). Again, none of these were more frequent in one
or the other group.
We did an additional analysis to evaluate the impact of neonatal death
in the index pregnancy on the prevalence of psychological problems.
When considering only the respondents with psychological problems,
the likelihood of a nonsurviving baby in the index pregnancy was higher
in FETO patients than in controls, paralleling what was already observed
among all participants (Table III).
Discussion
We did not observe differences in subsequent fertility, pregnancy and
gynecological outcomes in patients with fetuses with severe CDH
who had either fetoscopic surgery or who were expectantly managed
........................................................................................
Table I Demographic variables and pregnancy
outcomes in participants and nonparticipantsQ4 .
Nonparticipants Participants P-Value
FETO (n ¼ 204) 115 (56%) 89 (44%) 0.102
Controls (n ¼ 167) 109 (65%) 58 (35%)
Mean age at index
pregnancy (years)
30.5+6.3 31.1+5.9 0.312
Parity at baseline
0 93 (50%) 67 (53%) 0.720
≥1 93 (50%) 60 (47%)
Neonatal death in
index pregnancy
49% 39% 0.083
Mean age at survey
(years)
35.7+6.5 36.8+6.2 0.069
Mean interval index
pregnancy to study
invitation (months)
62.5+30.3 69.1+30.1 0.042
FETO, fetoscopic endoluminal tracheal occlusion.
Data are the pooled data from both centers and are n (%) or mean+ SD.
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Table II Essential baseline data and subsequent pregnancy outcomes in study participants treated by fetoscopic
endoluminal tracheal occlusion (FETO) or expectant management (Control).
FETO Controls P-Value
n (%) 89 (44%) 58 (35%)
Interval between index pregnancy and survey (months) 75.6+31.38 59.0+24.89 ,0.001
Previous obstetrical history at baseline
Parity at index pregnancya
0 40 (47%) 27 (64%) 0.101
≥1 45 (53%) 15 (36%)
Survival of CDH fetus in index pregnancy 53% 72% 0.028
Subsequent pregnancies
Further attempt to conceive 62 (70%) 27 (47%) 0.009
Of those attempting to conceive
Patients with 0 subsequent pregnancies 4 (6%) 3 (11%) 0.430
Patients with ≥1 subsequent pregnancies 58 (94%) 24 (89%)
Requiring for the ﬁrst time ART 0 (0%) 0 (0%)
Number subsequent pregnancies in all patients 90 39
No further attempt to conceive 27 (30%) 31 (53%) 0.009
Of those, related to the index pregnancy 6 (22%) 13 (42%) 0.188
Subsequent pregnancy outcome
Gestational age at deliveryb 0.957
Miscarriage (loss ,20 weeks) 12 (14%) 8 (22%)
Pregnancy loss 20–24 weeks 0 (0%) 0 (0%)
Delivery 24–28 weeks 0 (0%) 0 (0%)
Delivery 28–37 weeks 7 (8%) 2 (5%)
Delivery 37 weeks plus 69 (78%) 27 (73%)
Cumulative number of pregnancies with at least one of the following complications during pregnancyc 14 (23%) 7 (27%) 0.934
Exact numbers of pregnancies complicated with
Diabetes 5 4
Hypertension 4 1
Bleeding during pregnancy 2 3
Othersf 4 1
Cumulative number of pregnancies with at least one of the following complications at delivery or thereafterd 10 (17%) 1 (4%) 0.230
Exact numbers of pregnancies with
Hemorrhage at or immediately after delivery 4 0
Preterm labor and/or preterm rupture of the membranes 5 1
Othersg 1 0
Birthweight (kg) 3.39+0.48 3.37+0.38 0.810
Delivery modee
Vaginal delivery 43 (60.5%) 22 (81%) 0.086
Cesarean delivery 28 (39.5%) 5 (19%)
All percentages in the above table are calculated on patients with known data.
Data are mean+ SD or n (%).
For some parameters there were missing data:
aParity in the index pregnancy (FETO: 4; Controls: 16).
bGestational age at delivery (FETO: 2; Controls: 2).
cPregnancy complication(s) (FETO: 16; Controls: 3).
dComplications at delivery or thereafter (FETO: 17; Controls: 5).
eDelivery mode delivering .24 weeks (FETO: 5; Controls: 2) and unknown term at the end of pregnancy (FETO: 2; Controls: 2).
fOther complications during pregnancy FETO: placenta previa, cytomegalovirus infection in mother, placenta problem not otherwise speciﬁed, need for the use of lowmolecular weight
heparin not otherwise speciﬁed. In controls: hypothyroidism.
gComplications at delivery or thereafter FETO: manual removal of placenta.
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during the index pregnancy. Though persisting psychological problems
were frequent, theywerenotmorecommon in the fetal surgery patients.
In woman who had fetal surgery in the index pregnancy, persistent psy-
chological impact coincided with a poorer neonatal outcome.
Fetal surgeryessentially implies an intervention in anotherwisehealthy
mother. This may cause complications and side effects during the index
pregnancy, but theoretically it may also impact later reproductive life.
There is only limited data available on medium or long-term maternal
outcome after OFMS, though OFMS is already practiced for more than
20 years. Fetoscopy has been utilized since the late 90s yet no long or
medium term outcomes were so far reported (Wenstrom and Carr,
2014). In this study, we did not observe an adverse impact of fetoscopic
surgery on the wish to conceive. This is in line with what has been
observed for OMFS (Wilson et al., 2004, 2010). Conversely, there
were signiﬁcantly more women attempting a further pregnancy after
FETO. This may have several reasons. There were signiﬁcantly less sur-
vivors in the index pregnancy in FETO patients, what is in line with the
more severe nature of pulmonary hypoplasia in that group. Also, the
mean follow-up was 17 months longer in the FETO group than in con-
trols, which could also result in identiﬁcation of more women wanting
to conceive again.
Oneoutof the threepatientswhodidnotwish toconceive, speciﬁcally
related their decision to events in the index pregnancy. This was inde-
pendent of the nature of the management of the index pregnancy. The
average perinatal outcome of subsequent pregnancies was not different
in participants having undergone FETO or those expectantly managed.
Neither were there more pregnancy nor post-partum complications in
FETO participants than controls.
Though thenumberof patients is limited, not a singlemotherwhocon-
ceived after FETO reported problems with the uterine scar. This is in
contrast to what is reported for OMFS, where the former hysterotomy
is considered as a potential weak location prone to dehiscence and/or
rupture. Because of the risk for uterine rupture during pregnancy or
labor, those women are advised to deliver by elective repeat Cesarean
delivery at 37 weeks. This is based on relatively striking rates of
uterine dehiscence (14%), rupture (14%) and Cesarean hysterectomy
(3%) in the experience reported by the Children’s Hospital of Philadel-
phia (Wilson et al., 2004, 2010). These dehiscence and rupture
numbers are in the range of what is reported after classical Cesarean de-
livery (Wilson et al., 2010).Conversely, we did not see any such events in
our FETO patients, who in 61% of cases delivered later vaginally.
A large percentage of woman (43%) reported later psychological or
emotional problems, yet there was no difference between the operated
and conservatively managed groups. Psychological problems in women
who carried and/or delivered a fetuswith a severe congenital malforma-
tion have been often described, but none of these studies included
patients undergoing fetal therapy. In our study, the psychological
burden of the index pregnancy and decision to pursue fetal surgery com-
pounds the existing maternal psychological adjustment required during
pregnancy. Carrying a fetus or delivering a neonate with a congenital
anomaly should therefore not be underestimated. Our data should
prompt pre-emptive measures to organize prospective support during
and after the index pregnancy (Leithner et al., 2004; Aite et al., 2009).
In the FETO group, there was a relation between the survival of the
baby in the index pregnancy and the prevalence of psychological pro-
blems. Signiﬁcantly, more women reported emotional problems when
Figure1 Flow diagramof the subsequent attempts to conceive after treatment by fetoscopic endoluminal tracheal occlusion (FETO) or expectantman-
agement (Control). Q3
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their baby died. This was not observed in the control group. Obviously
this may be due to fetal surgery itself, yet may as well be explained by
the higher likelihood of post-natal death in the fetal surgery patients,
who have a poorer prognosis.
This study has a number of weaknesses. First, we used no condition
speciﬁc validated questionnaires. In their absence, we modiﬁed the
only questionnaire available. This questionnaire was designed to specif-
ically ask about obstetrical outcomes that could theoretically be
altered by the fetal surgical procedure (Wilson et al., 2004, 2010).
Using very similar questionnaires we think that making a comparison
with OFMS is reasonable. Regardless, both our study and those ones
on OMFS patients could not detect an adverse impact of fetal surgery
on subsequent pregnancy, fertility and gynecological outcomes. This
use of an unvalidated instrument should be taken into account interpret-
ing the results. The assessment of the long-term psychological impact
using validated instruments is an interesting subject for further research.
Another limitation is the relative low response rate (40%), which was
lower than what Wilson et al. described (57%). Another generic limita-
tion is that we used self-reported outcomes. This may lack accuracy
for precise determination of the occurrence, nature and severity of
some medical complications. Also for some rarer complications the
number of events was very low or zero, eventually making a statistical
comparison virtually meaningless. Finally, the mean follow-up period of
only 5.8 years and a mean age of around 37 years when being polled,
may lead to an underestimation of subsequent gynecological problems,
which typically occur later in life.
The strength of this study is that it is the ﬁrst reporting on reproductive
outcomes following fetoscopic surgery using an appropriate control
group. Though numbers are small, indications for fetal surgery are
limited such large data sets are not easily obtained, and we use compar-
able numbers of patients to previous studies. Despite the limitations, it
seems reasonable to conclude that fetoscopic surgery for CDH does
not seem to have adverse maternal effects on the medium term, yet
most of the impact seems to be due to the burden of a severe congenital
birth defect (Leithner et al., 2004; Aite et al., 2009).
Conclusion
In this controlled study, we did not observe a relevant impact of fetal
surgery for CDH on future fertility, obstetrical and early gynecological
outcomes. A signiﬁcant number (43%) of participants reported a
serious psychological impact of the index event, irrespective of its man-
agement during pregnancy.
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